Recruiting

MIMICMixed Reality for MitraClip Implantation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Cardiovascular Diseases+1

+ Heart Diseases

+ Heart Valve Diseases

Over 18 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: August 2024
See protocol details

Summary

Principal SponsorNemocnice AGEL Trinec-Podlesi a.s.
Study ContactJan Hecko, Ing, Ph.D.More contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: August 15, 2024

Actual date on which the first participant was enrolled.

The advent of mixed reality (MR) technology, especially when integrated with Hololens 2.0 and specialized software for three-dimensional DICOM image visualization, offers promising avenues for enhancing precision and spatial awareness in interventional cardiology procedures. This case series aims to preliminarily evaluate the impact of MR on MitraClip implantation processes, setting the foundation for a comprehensive pilot study.

Official TitleLeveraging Mixed Reality in MitraClip Implantation: a Preliminary Case Series Toward a Pilot Study
NCT06539416
Principal SponsorNemocnice AGEL Trinec-Podlesi a.s.
Study ContactJan Hecko, Ing, Ph.D.More contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

14 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Cardiovascular DiseasesHeart DiseasesHeart Valve DiseasesMitral Valve Insufficiency

Criteria

3 inclusion criteria required to participate
Adults aged over 18 years
Patients diagnosed with mitral valve regurgitation requiring MitraClip implantation
Ability to provide informed consent and comply with study procedures
3 exclusion criteria prevent from participating
Patients with contraindications for MR technology (e.g., MRI incompatibility)
Individuals unable to comply with study procedures due to physical or cognitive impairments
Pregnant or breastfeeding women

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Hospital AGEL Trinec-Podlesi a.s.

Třinec, CzechiaOpen Hospital AGEL Trinec-Podlesi a.s. in Google Maps
Recruiting
One Study Center